NEW YORK--(BUSINESS WIRE)--Celmatix, a personalized medicine company focused on fertility and women’s health, today announced the appointment of Ardy Arianpour to its Corporate Advisory Board. Mr. Arianpour brings to the Board more than 14 years of experience as a leader in commercializing genomic technologies, including numerous pioneering molecular diagnostic tests.
